QQ客服 官方微博 反馈留言

浏览/检索结果: 共38条，第1-10条 帮助 限定条件 发表日期：2018    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Immunotherapeutic interventions of Triple Negative Breast Cancer 期刊论文 JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 卷号: 16 作者:  Li, Zehuan;  Qiu, Yiran;  Lu, Weiqi;  Jiang, Ying;  Wang, Jin 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Triple Negative Breast Cancer  Immunotherapy  Chemotherapy  Antibody therapies  Exosome   A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia 期刊论文 FRONTIERS IN ONCOLOGY, 2018, 卷号: 8 作者:  Schneider, Dina;  Xiong, Ying;  Hu, Peirong;  Wu, Darong;  Chen, Weizao 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 AML  lentiviral vector  CAR-T  CD33  VH  immunotherapy  phage display   Neutralizing TGF-beta promotes anti-tumor immunity of dendritic cells against pancreatic cancer by regulating T lymphocytes 期刊论文 CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 卷号: 43, 期号: 2 作者:  Pu, Ning;  Zhao, Guochao;  Gao, Shanshan;  Cui, Yutong;  Xu, Yadong 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 pancreatic ductal adenocarcinoma  DCs  TGF-beta  immunotherapy  prognosis   Interleukin-15 suppresses gastric cancer liver metastases by enhancing natural killer cell activity in a murine model 期刊论文 ONCOLOGY LETTERS, 2018, 卷号: 16, 期号: 4 作者:  Wang, Wei;  Jin, Jiejie;  Dai, Faxiang;  Long, Ziwen;  Liu, Xiaowen 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 interleukin-15  liver metastasis  gastric cancer  cancer immunotherapy  natural killer cell   Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials 期刊论文 ONCOIMMUNOLOGY, 2018, 卷号: 7, 期号: 12 作者:  Huang, Qingyuan;  Zhang, Hua;  Hai, Josephine;  Socinski, Mark A.;  Lim, Eric 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 anti-PD-1  atezolizumab  immunotherapy  nivolumab  non-small cell lung cancer  pembrolizumab   HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 卷号: 67, 期号: 1 作者:  Wang, Jiajun;  Liu, Li;  Qu, Yang;  Xi, Wei;  Xia, Yu 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Metastatic renal-cell carcinoma  Tyrosine kinase inhibitors  Human leukocyte antigen class I  Cytotoxic T lymphocyte  Survival  Biomarker   Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer 期刊论文 ONCOIMMUNOLOGY, 2018, 卷号: 7, 期号: 8 作者:  Wang, Shuai;  Hao, Jiatao;  Wang, Hao;  Fang, Yong;  Tan, Lijie 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 lung cancer  immunotherapy  checkpoint inhibitors  PD-1  PD-L1  meta analysis   Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer 期刊论文 JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2018, 卷号: 14, 期号: 9 作者:  Xia, Qingming;  Gong, Chunai;  Gu, Fenfen;  Wang, Zhuo;  Hu, Chuling 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05 Multi-Walled Carbon Nanotubes  CpG  Immunotherapy  H3R6 Polypeptide  Prostate Cancer   Therapeutic cancer vaccines: From initial findings to prospects 期刊论文 IMMUNOLOGY LETTERS, 2018, 卷号: 196 作者:  Song, Qian;  Zhang, Cheng-dong;  Wu, Xiang-hua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Cancer vaccine  Tumor antigen  Neoantigen  Immunotherapy   Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy 期刊论文 ONCOIMMUNOLOGY, 2018, 卷号: 7, 期号: 7 作者:  Yue, Chunyan;  Jiang, Yubo;  Li, Ping;  Wang, Yuehua;  Xue, Jian 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 advanced solid tumor  circulating tumor cells (CTCs)  immunotherapy  programmed death-ligand 1 (PD-L1)  semi-quantitative analysis